The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

“Semaglutide is very effective for weight loss,” says Dr. Saunders. In fact, a 2021 phase 3 clinical trial found that 2.4 ...

With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...

Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...

Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.

Preparing for semaglutide injection therapy involves more than just starting a new medication. Many people find that making simple changes in their daily routine can help reduce side effects and […] ...

Oral semaglutide is already approved for Type 2 diabetes at doses up to 14 mg daily. Higher doses (25 mg, 50 mg) have been studied for weight loss and may offer similar results to the Wegovy 2.4 ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used that there have been worldwide shortages of semaglutide, also known by ...

This is especially true with semaglutide, where you have a choice of pill or injection of the same medication. Here are some of the considerations for pills: They’re often more affordable.

However, another study found that 56.2% of patients who ceased semaglutide injections for one year remained at around the same weight or continued to lose more after treatment.